NovoCure Ltd — Director's Dealing 2018

Apr 20, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-04-18

Reporting Person: Kirson Eilon D. (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-18	Ordinary Shares	M	76869	$3.44	Acquired	116451	Direct
2018-04-18	Ordinary Shares	S	76869	$24.00	Disposed	39582	Direct
2018-04-18	Ordinary Shares	M	70956	$3.44	Acquired	110538	Direct
2018-04-18	Ordinary Shares	S	70956	$24.00	Disposed	39582	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-18	Options to Buy Ordinary Shares	$3.44	M	76869	Acquired		Ordinary Shares (76869)	Direct
2018-04-18	Options to Buy Ordinary Shares	$3.44	M	70956	Acquired		Ordinary Shares (70956)	Direct

Footnotes

F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson.

F2: Fully vested as of the date hereof.